HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
RI 624
Description
RI 624 is a novel humanized monoclonal antibody that blocks nerve growth factor (NGF), a key mediator of acute and chronic pain. RI 624 is being developed by Rinat and is currently in Phase I clinical trials.
No brand information found.
